Celanese Corp: Form 10-Q for the period ended Mar 31, 2022
Filed with the SEC on Apr 29, 2022 and accepted by EDGAR at Apr 29, 2022, 16:24 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-01-01 to 2022-03-31 | $2.54bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2022-01-01 to 2022-03-31 | $1.79bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2022-01-01 to 2022-03-31 | $745.0m | us-gaap:GrossProfit |
| Research and development | 3 months2022-01-01 to 2022-03-31 | $24.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2022-01-01 to 2022-03-31 | $174.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2022-01-01 to 2022-03-31 | $531.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2022-01-01 to 2022-03-31 | $35.0m | us-gaap:InterestExpense |
| Income tax | 3 months2022-01-01 to 2022-03-31 | $112.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-01-01 to 2022-03-31 | $502.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-01-01 to 2022-03-31 | $4.61 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-01-01 to 2022-03-31 | $4.64 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-01-01 to 2022-03-31 | 108,917,577 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2022-01-01 to 2022-03-31 | $316.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2022-01-01 to 2022-03-31 | $137.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2022-01-01 to 2022-03-31 | $73.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2022-01-01 to 2022-03-31 | $17.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | At period end2022-03-31 | $4.20bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-03-31 | $12.43bn | us-gaap:Assets |
| Current liabilities | At period end2022-03-31 | $2.55bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2022-03-31 | $3.13bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2022-03-31 | $860.0m | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2022-03-31 | $4.61bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001306830-22-000098. Last ingested by Listed: Nov 13, 2026, 16:24 ET. Listed shows no prices and gives no investment advice.